TechFlow news, according to the official information disclosure system of Hong Kong Stock Exchange, Huajian Medical (01931.HK) announced on July 17 the official launch of the "IVDNewCo Exchange" ecosystem initiative, unveiling the world's first RWA exchange ecosystem focused on high-tech assets in medical innovative pharmaceuticals NewCo, along with a dedicated IVDD stablecoin issuance program.
It is reported that the company is actively advancing a landmark strategic initiative—building an exchange ecosystem centered on high-tech assets in medical innovative pharmaceuticals under the "NewCo + RWA + Web3" framework. This ecosystem will be named "IVDNewCo Exchange" and will be supported by a proprietary stablecoin (IVDDollar "IVDD").
This strategy aims to disrupt traditional rules of the pharmaceutical industry by integrating Web3 technologies—including tokenization of real-world assets (RWA), blockchain-based trading, and stablecoin mechanisms—to enhance global liquidity, financing efficiency, and accessibility of medical innovative pharmaceutical assets. The following sections detail the strategic vision, progress, core advantages, and future roadmap of this ecosystem.
